BloombergLean L·
Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug
Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.
Read at Bloomberg →
Markets · 1 sources covering this
Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug
Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/d4fb93efcfbb5a78a872e80de454723dea685503" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug"></iframe>
